Lonza says 2012 growth was solid, but more restructuring due
January 29, 2013Manufacturing and Production Arch, CMO, Lonza
Swiss contract manufacturing organisation (CMO) and ingredients supplier Lonza posted a 46% increase in revenues to 3.93 billion francs last …
Synthon opens ADC plant in the Netherlands
January 29, 2013Manufacturing and Production ADC, Synthon
Synthon Biopharmaceuticals says it has opened officially opened a new antibody-drug conjugate (ADC) manufacturing facility in Nijmegen, the Netherlands. The …
Boehringer calls for ‘game changing’ ideas in health
January 29, 2013Medical Communications, Research and Development, Sales and Marketing Ashoka Changemakers, Boehringer Ingelheim
Boehringer Ingelheim has teamed up with a social entrepreneur network to promote health projects in developing countries. This is the …
New government chairman for pharmacy programme board
January 29, 2013Manufacturing and Production, Medical Communications, Sales and Marketing Ken Jarrold, NHS, government
The Department of Health has announced the appointment of Ken Jarrold to chair the programme board for the government’s work …
NICE hits back at ‘limited’ EC study
January 28, 2013Sales and Marketing ABPI, EC, NHS, NICE, QALY, Whitehead
NICE has delivered a robust defence of the methods by which it arrives at a judgment on the value of …
Takeda gets US diabetes approval
January 28, 2013Sales and Marketing FDA, Nesina, Takeda, diabetes
Takeda has been given US approval for its diabetes drug Nesina and two variations on it for the treatment of …
NHS patient data and clinical research – coming together at last?
January 28, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Les Rose, NHS, R&D, clinical, records, transparency
In the mid-1990s, an NHS teaching hospital close to my offices invited proposals for expanding its clinical trials unit. Hitherto …
GSK appoints Hans Wijers to its Board as a non-executive director
January 28, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GSK, hans Wijers
GSK has confirmed the appointment of Hans Wijers to its Board as a non-executive director with effect from April. The …
J&J seeks end to Doxil shortage as Ben Venue signs consent decree
January 28, 2013Manufacturing and Production Ben Venue, Boehringer, Caelyx, Doxil, J&J, JJ, Janssen
Johnson & Johnson says it has taken steps to establish new supplies of its cancer drug Doxil/Caelyx, which remains in …
Vaccine manufacturing emerges as outsourcing market
January 28, 2013Manufacturing and Production R&D, Vaccine, outsourcing
Healthy growth in the market for vaccines – coupled with high production costs – look set to create a vaccine …
Life Tech gets bigger in bioproduction with BAC buy
January 28, 2013Manufacturing and Production BAC, Life Technologies
Life Technologies has expanded its position in bioprocessing technologies with the acquisition of Dutch protein purification specialist BAC. Carlsbad, US-based …
Scotland’s medicines bill can shrink further, says report
January 25, 2013Sales and Marketing PPRS, Scotland, VBP, prescribing
An official review of primary care prescribing in Scotland has welcomed savings made, but says further efficiencies are possible.Audit Scotland …
Abbott finishes strongly before spin-off
January 25, 2013Sales and Marketing AbbVie, Abbott, Q4 2012
Abbott has presented its full-year results for 2012 – the last in which many of its products will appear, following …
NICE recommends two cystic fibrosis treatments
January 25, 2013Sales and Marketing Colobreath, Forest Labs, Novartis, Tobi Podhaler, cystic fibrosis
NICE has given final recommendation to two new inhalers for cystic fibrosis (CF) patients.Forest Lab’s Colobreath (colistimethate sodium) and Novartis’ …
Allergan in $958m neurology deal
January 25, 2013Sales and Marketing Allergan, CNS, MAP Pharmaceuticals, migraine
Allergan is to pay $958m for MAP Pharmaceuticals in a deal which sees both companies hoping to reap the benefits …
Flying start to 2013 for Watermeadow Medical
January 24, 2013Medical Communications
Watermeadow Medical has started the new year with an office relocation from Knutsford to fully refurbished, larger office space in …
Novartis’ 2012 results flat
January 24, 2013Sales and Marketing Bexsero, Jakavi, Novartis, generics, results
Generic competition has put a dent in Novartis’ financial results for 2012, with net sales down 3% year on year …
EU approval for Novo Nordisk diabetes drugs
January 24, 2013Sales and Marketing Novo Nordisk, Ryzodeg, Tresiba
Novo Nordisk is celebrating after European regulators approved two of its drugs for the treatment of adults with diabetes. The …
Jörg Reinhardt to leave Bayer for Novartis
January 24, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bayer, Novartis, Reinhardt
The chairman of the Board and member of the Bayer executive council Dr Jörg Reinhard is stepping down from his …
Watson buys women’s health specialists
January 23, 2013Research and Development, Sales and Marketing Actavis, Uteron, Watson, women
Watson has completed the acquisition of Uteron Pharma, a Belgium R&D-based firm specialising in women’s health products. The world’s third-largest …
Latest content
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations
